Current state and future directions of basic research in rheumatoid arthritis

Current state and future directions of basic research in rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial inflammation and joint destruction. Despite advances in biologic therapies targeting inflammatory mediators such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, Janus kinase (JAK), and B cells, many patients do...

Full description

Saved in:

Bibliographic Details
Main Authors:	Byeongzu Ghang, Jin Kyun Park, Ji Hyeon Ju, Seungwoo Han
Format:	Article
Language:	English
Published:	Korean College of Rheumatology 2025-07-01
Series:	Journal of Rheumatic Diseases
Subjects:	rheumatoid arthritis anti-citrullinated protein antibody synovial inflammation immune dysregulation disease heterogeneity
Online Access:	http://www.jrd.or.kr/journal/view.html?doi=10.4078/jrd.2024.0151
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SYNOVIAL MEMBRANE CHANGES IN PATIENTS WITH RHEUMATOID ARTHRITIS REVEALED DURING ARTHROSCOPY
by: E. B. Komarova
Published: (2017-07-01)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
by: Hui-Chun Yu, et al.
Published: (2019-01-01)

ACCP-negative rheumatoid arthritis – clinical and immunological features
by: D. A. Dibrov
Published: (2022-07-01)

Rheumatoid factor and antibodies against cyclic citrullinated peptide in patients without rheumatoid arthritis
by: N. V. Bunchuk
Published: (2023-01-01)

Markers of angiogenesis in patients with rheumatoid arthritis depending on its clinical characteristics
by: E. B. Komarova
Published: (2017-03-01)

Bone destruction in rheumatoid arthritis: role of autoantibodies
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2013-06-01)

Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease
by: E. L. Nasonov, et al.
Published: (2023-06-01)

Cerebrovascular reactivity depending on rheumatoid factor and anticitrullinated protein antibody positivity in hypertensive patients with rheumatoid arthritis
by: N. V. Rebrova, et al.
Published: (2022-07-01)

EXTRA-ARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev
Published: (2018-07-01)

Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis
by: D. A. Dibrov, et al.
Published: (2023-04-01)

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2011-06-01)

AUTOANTIBODIES TO CIRTULLINATED ANTIGENS FOR DIAGNOSIS AND PREDICTION OF CLINICAL COURSE IN EARLY RHEUMATOID ARTHRITIS
by: I. B. Belyaeva, et al.
Published: (2014-07-01)

DIAGNOSTIC MARKERS AND CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING DMARDS
by: Maria Sergeevna Voronina, et al.
Published: (2012-10-01)

Factors predicting early discontinuation of methotrexate as a first-line treatment for rheumatoid arthritis in Italy: Results from the GISEA registry
by: Andreina Manfredi, et al.
Published: (2019-01-01)

Anti-cyclic citrullinated peptide antibodies – a role in rheumatoid arthritis and the possibility of seroconversion: A focus on abatacept
by: N. V. Chichasova
Published: (2017-03-01)

Autoantibodies as prognostic markers in rheumatoid arthritis
by: Carl Turesson, et al.
Published: (2025-06-01)

THE 2016 EULAR GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF EARLY ARTHRITIS
by: E. L. Nasonov
Published: (2017-04-01)

Seropositive juvenile rheumatoid arthritis: analysis of the spectrum of clinical manifestations and therapy according to a retrospective study
by: М. I. Kaleda, et al.
Published: (2021-02-01)

Cytokines, chemokines and antibodies against histone-3/4 citrullinated peptides in rheumatoid arthritis patients with pulmonary fibrosis
by: Linda Johansson, et al.
Published: (2025-07-01)

Upregulation of interferon-γ response genes in monocytes and T cells identified by single-cell transcriptomics in patients with anti-citrullinated peptide antibody-positive early rheumatoid arthritis
by: Bong-Ki Hong, et al.
Published: (2025-01-01)

Triple positivity for autoantibodies in patients with rheumatoid arthritis is associated with a severe course of the disease but not with bone turnover markers
by: Tomasz Budlewski, et al.
Published: (2025-04-01)

Relation of cytokine profile and antibody values to post-translational protein modifications in patients with rheumatoid arthritis (preliminary data)
by: D. А. Dibrov, et al.
Published: (2024-04-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

Anti-Modified Peptide Antibodies (AMPAs) in Rheumatoid Arthritis: Study of the Diagnostic Value of Citrullinated, Homocitrullinated, and Acetylated Fibrin/Filaggrin Chimeric Peptides
by: Isabel Haro, et al.
Published: (2024-11-01)

Exercise prescription in the management of rheumatoid arthritis
by: K. Nolte, et al.
Published: (2013-08-01)

DIAGNOSTIC VALUE OF SEROLOGICAL MARKERS OF RHEUMATOID ARTHRITIS
by: Aleksei Leonidovich Maslaynski, et al.
Published: (2012-10-01)

Neutrophils in Rheumatoid Arthritis Synovium: Implications on Disease Activity and Inflammation State
by: Deng Y, et al.
Published: (2025-04-01)

Synovial macrophages drive severe joint destruction in established rheumatoid arthritis
by: Dengfeng Wu, et al.
Published: (2025-04-01)

Comparative Analysis of Rheumatoid Factor Levels by Immune Turbidimetry and Latex Agglutination Assays among Anti-Cyclic Citrullinated Peptide-Positive Rheumatoid Arthritis Patients
by: Bineeta Kashyap, et al.
Published: (2020-10-01)

Relationship of immunogenetic and immunologic markers and their influence on disease activity and radiological progression in patients with early rheumatoid arthritis
by: N V Demidova
Published: (2009-06-01)

INVESTIGATION OF CANDIDATE GENE POLYMORPHISMS IN AN IMMUNE RESPONSE AS MARKERS FOR THE RISK OF DEVELOPING RHEUMATOID ARTHRITIS AND PRODUCING AUTOANTIBODIES
by: I. A. Guseva, et al.
Published: (2016-03-01)

Meta-analysis identifies the major impact of patient classification on the ACPA association with rheumatoid arthritis-associated interstitial lung disease (RA-ILD)
by: Bartosz Kaczmarczyk, et al.
Published: (2025-07-01)

Histamine index and clinical expression of rheumatoid arthritis activity
by: Tomić-Lučić Aleksandra P., et al.
Published: (2010-01-01)

Synovial Fluid Markers and Extracellular Vesicles in Rheumatoid Arthritis
by: Veronika Smolinska, et al.
Published: (2024-11-01)

THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Elena Nikolayevna Aleksandrova, et al.
Published: (2012-02-01)

ACPA-Induced ATP release and K+ efflux trigger NLRP3 inflammasome activation in rheumatoid arthritis
by: Li Cai, et al.
Published: (2025-07-01)

Bone resorption during therapy with denosumab in patients with rheumatoid arthritis, positive for the main immunological markers
by: P. S. Kovalenko, et al.
Published: (2022-11-01)

Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies – comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis
by: Tineke J. van Wesemael, et al.
Published: (2025-05-01)

Peculiarities of immunological manifestations in patients with rheumatoid arthritis in the presence of chronic infection with <i>Helicobacter pylori</i> variant encoding cytotoxin-associated gene A
by: A. V. Aleksandrov, et al.
Published: (2023-06-01)

Proteomic analysis of infiltrating neutrophils from rheumatoid arthritis synovial fluid and their contribution to protein carbamylation
by: Xueting Chen, et al.
Published: (2025-04-01)